Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Healthcare Worker Shortages are Contributing to a Challenging Flu and RSV Season

Is the U.S. prepared for a healthcare emergency this winter? A shortage of healthcare providers is setting the stage for a crisis. Indicators show this year’s flu season will be pretty severe, and the RSV season, which typically occurs between late December to Mid-February, is already showing signs of case spikes. Rachell Neill, Co-Founder…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Is the U.S. prepared for a healthcare emergency this winter? A shortage of healthcare providers is setting the stage for a crisis. Indicators show this year’s flu season will be pretty severe, and the RSV season, which typically occurs between late December to Mid-February, is already showing signs of case spikes.

Rachell Neill, Co-Founder of Carex Consulting Group, says this combination of flu and RSV cases, on top of a lingering pandemic, is burning out healthcare workers.

“What it’s doing is taking a post-pandemic workforce and putting them back into a position of needing flexibility. It’s especially going to impact primary caregivers because if children get sick and are unable to go to school, they’re more likely to have a severe illness, so if they get the flu and that gets coupled with RSV, there’s a higher likelihood of hospitalization.

Each year the CDC estimates 2.1 million outpatient visits among children younger than five years old due to RSV and 58,000-80,000 hospitalizations.

“It’s going to put a strain on our health systems, the healthcare workers, and the parents or primary caregivers that are working,” Neill says. “We will also see an impact on companies now requiring workers to return to the office.”

Worker burnout is a genuine concern in the healthcare industry, and healthcare systems and communities are working to help alleviate some of the strains. These issues may benefit from loan forgiveness programs to technology automation solutions that increase efficiency and reduce work overload, but challenges remain.

If the situation remains, the U.S. will have a predicted nursing shortage of between 200,000 and 450,000 RNs by 2025. That will result in a 10 to 20 percent nursing gap to-patient ratio as patient needs increase and the number of new nurses decreases. The AAMC projects primary care physician shortages between 17,800 and 48,000 and non-primary care physician shortages between 21,000 and 77,100 by 2034.

How can healthcare increase its workforce and take seasonal healthcare challenges head-on? The American Hospital Association lists several steps, which include: congress passing legislative priorities to stimulate job growth in the healthcare sector, lifting the cap on Medicare residency positions to enhance access to care, and helping America’s hospitals better meet the needs of the communities they serve, supporting the Future Advancement of Academic Nursing Act, and regulating anti-competitive pricing practices of nurse staffing agencies, which have led to many nurses leaving full-time positions within hospital networks.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512